David M. Treiman, MD

Skip Navigation



Advanced Search



David M. Treiman, MD


David M .Treiman, MD
Newsome Chair in Epileptology
Director, Epilepsy Program
Director, Clinical Neurophysiology Laboratories
Director, Clinical Neurophysiology/Epilepsy Fellowship Program
Principal Investigator, Laboratory for Translational Epilepsy Research

David M. Treiman, MD, is the Newsome Chair in Epileptology and Director of the Epilepsy Center, the Clinical Neurophysiology Laboratories, the Clinical Neurophysiology/Epilepsy Fellowship Program, and the Laboratory for Translational Epilepsy Research at Barrow Neurological Institute. He is Professor of Neuroscience and Bioengineering at Arizona State University, Clinical Professor of Neurology at the University of Arizona College of Medicine, and Professor of Neurology at Creighton University School of Medicine. He is also Editor-in-Chief of Epilepsy Research.

Dr. Treiman completed his undergraduate degree at the University of California – Berkeley, graduated from Stanford University School of Medicine, and then trained in internal medicine and neurology at Duke University Medical Center. After service in the United States Navy Medical Corps he joined the faculty at the University of California – Los Angeles, where he rose to the rank of professor. In 1997 he became the Chair of Neurology at the University of Medicine and Dentistry of New Jersey – Robert Wood Johnson Medical School, but returned to the West after 4 years.

Dr. Treiman’s research focuses on treatment issues in epilepsy including mechanisms and treatment of status epilepticus, development of new drugs and novel nonpharmacological interventions for the treatment of epilepsy, and the prediction and prevention of epileptogenesis after status epilepticus and traumatic brain injury.

 

Education, Training, and Previous Positions

  • 2002-2009: Vice Chair, Division of Neurology, Barrow Neurological Institute
  • 2000-2001: Professor, Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick
  • 1997-2000: Professor and Chairman, Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway, New Jersey
  • 1990-1997: Professor in Residence, Department of Neurology, UCLA School of Medicine, Los Angeles, California
  • 1985-1990: Associate Professor in Residence, Department of Neurology, UCLA School of Medicine
  • 1978-1985: Assistant Professor in Residence, Department of Neurology, UCLA School of Medicine
  • 1980-1997: Co-Director, VA Southwest Regional Epilepsy Center, VA West Los Angeles Medical Center
  • 1978-1997: Staff Neurologist, VA West Los Angeles Medical Center
  • 1976-1978: Director, Postgraduate Physician Training Program, U.S. Naval Regional Medical Center, Yokosuka, Japan
  • 1975-1978: Chief of Neurology, U.S. Naval Regional Medical Center, Yokosuka, Japan
  • 1973-1975: Chief of Neurology, U.S. Naval Regional Medical Center, Jacksonville, Florida
  • 1972-1973: Chief Resident, Neurology, Duke University Medical Center, Division of Neurology, Durham, North Carolina
  • 1971-1972: Senior Assistant Resident, Duke University Medical Center, Division of Neurology
  • 1971-1972: Research Fellow, Division of Neurology, Duke University Medical Center, Neurobiology
  • 1971-1971: Chief Resident, Duke University Medical Center, Division of Neurology
  • 1969-1971: Junior Assistant Resident, Duke University Medical Center, Division of Neurology, Department of Medicine
  • 1968-1969: NIH Postdoctoral Fellow, Molecular Biology, Duke University Training Program
  • 1967-1968: Intern, Duke University Medical Center, Department of Medicine
  • 1962-1967: MD, Stanford University School of Medicine, Stanford, California
  • 1958-1962: BA, University of California - Berkeley

 

Selected Professional Memberships and Appointments

  • American Board of Psychiatry and Neurology
  • American Academy of Neurology, Fellow
  • American Association for the Advancement of Science
  • American Epilepsy Society
  • American Neurological Association
  • Society for Neuroscience
  • J. Kiffi Penry Epilepsy Minifellowship Advisory Board

 

Selected Honors and Awards

  • 1992-2013: Best Doctors in America
  • 2002: Hans Berger Distinguished Scholar Award, 30th Annual Hans Berger Symposium, Medical College of Virginia
  • 1998: The Hans Berger Lectureship, Hans Berger Symposium, Medical College of Virginia
  • 1985: Prize for Best Published Controlled Clinical Trial of an Antiepileptic Drug, VA Epilepsy Cooperative Study Group, International League against Epilepsy
  • 1967: National Foundation Merit Award, Stanford University School of Medicine
  • 1962-1967: Redwood Prince Clark Scholarship, Stanford University School of Medicine
  • NIH Student Research Training Grant, Stanford University School of Medicine

 

Selected Publications

  1. Steinmetz PN, Cabrales E, Wilson MS, Baker CP, Thorp CK, Smith KA, Treiman DM. Neurons in the human hippocampus and amygdala respond to both low- and high-level image properties. J Neurophysiol. Jun 2011;105(6):2874-2884.

  2. Good LB, Sabesan S, Marsh ST, Tsakalis K, Treiman DM, Iasemidis LD. Nonlinear dynamics of seizure prediction in a rodent model of epilepsy. Nonlinear Dynamics Psychol Life Sci. Oct 2010;14(4):411-434.

  3. Treiman DM, Meyers PD, Walton NY, Collins JF, Colling C, Rowan AJ, Handforth A, Faught E, Calabrese VP, Uthman BM, Ramsay RE, Mamdani MB. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med. Sep 17 1998;339(12):792-798.

  4. Mattson RH, Cramer JA, Collins JF. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group. N Engl J Med. Sep 10 1992;327(11):765-771.

  5. Walton NY, Treiman DM. Lorazepam treatment of experimental status epilepticus in the rat: relevance to clinical practice. Neurology. Jun 1990;40(6):990-994.

  6. Treiman DM, Walton NY, Kendrick C. A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus. Epilepsy Res. Jan-Feb 1990;5(1):49-60.

  7. Walton NY, Treiman DM. Experimental secondarily generalized convulsive status epilepticus induced by D,L-homocysteine thiolactone. Epilepsy Res. Mar-Apr 1988;2(2):79-86.

  8. Treiman DM. Epilepsy and violence: medical and legal issues. Epilepsia. 1986;27 Suppl 2:S77-104.

  9. Mattson RH, Cramer JA, Collins JF, Smith DB, Delgado-Escueta AV, Browne TR, Williamson PD, Treiman DM, McNamara JO, McCutchen CB, et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med. Jul 18 1985;313(3):145-151.

  10. Delgado-Escueta AV, Wasterlain C, Treiman DM, Porter RJ. Current concepts in neurology: management of status epilepticus. N Engl J Med. Jun 3 1982;306(22):1337-1340.
Bottom of Navigation
 

Legal & Privacy Notices

 

Payment Assistance

Contact Us

Hospital Accreditation

© 2014 Dignity Health

Barrow Neurological Institute
350 W. Thomas Road
Phoenix, AZ 85013
(602) 406-3000